High-fidelity, efficient, and reversible labeling of endogenous proteins using CRISPR-based designer exon insertion.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34100715.
- Also identified by DOI 10.7554/eLife.64911 and PMC identifier 8211447.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Precise and efficient insertion of large DNA fragments into somatic cells using gene editing technologies to label or modify endogenous proteins remains challenging. Non-specific insertions/deletions (INDELs) resulting from the non-homologous end joining pathway make the process error-prone. Further, the insert is not readily removable. Here, we describe a method called <i>CRISP</i>R-mediated <i>i</i>nsertion of <i>e</i>xon (CRISPIE) that can precisely and reversibly label endogenous proteins using CRISPR/Cas9-based editing. CRISPIE inserts a designer donor module, which consists of an exon encoding the protein sequence flanked by intron sequences, into an intronic location in the target gene. INDELs at the insertion junction will be spliced out, leaving mRNAs nearly error-free. We used CRISPIE to fluorescently label endogenous proteins in mammalian neurons in vivo with previously unachieved efficiency. We demonstrate that this method is broadly applicable, and that the insert can be readily removed later. CRISPIE permits protein sequence insertion with high fidelity, efficiency, and flexibility.
Medical subject headings
- Animals
- CRISPR-Cas Systems
- CRISPR-Cas Systems/genetics
- Cell Line, Tumor
- Exons
- Exons/genetics
- Gene Editing
- Gene Editing/methods
- Humans
- Mice
- Mutagenesis, Insertional
- Mutagenesis, Insertional/genetics
- Neurons
- Neurons/cytology
- Proteins
- Proteins/analysis
- Proteins/chemistry
- Proteins/genetics
- Proteins/metabolism